Medical News

A Randomized Phase III Trial Comparing Adjuvant Single-agent...
Annals of oncol

In patients with curatively D2-resected, stage II/III, node-positive GC, adjuvant SOX, or SOX/RT was effective in...

03 Dec 2020

Propensity Score-matched Analysis of Systemic Chemotherapy v...
BMC Cancer

The current study demonstrated that, when compared to systemic CT, the adoption of salvage HT for patients with...

01 Dec 2020

Newly Diagnosed and Relapsed Follicular Lymphoma: ESMO Clini...
Annals of Oncol

This updated ESMO Clinical Practice Guideline provides key recommendations on the management of follicular lymphoma...

30 Nov 2020

Short-term Mortality Risks Among Patients with Non-metastati...
BMC Cancer

In summary, death from non-bladder cancer cause contributed to almost half of all deaths in bladder cancer...

26 Nov 2020

Our Publications

Pomalong (Pomalidomide) Monograph

Pomalidomide-dexamethasone is a standard of care in patients with relapsed/refractory multiple myeloma following exhaustion of treatment options.

Q & A on Imatinib- Focused on CML

Imatinib, a tyrosine kinase inhibitor, induces durable responses in the majority of CML patients and is currently the standard of care for CML. This...

Q & A on Imatinib- Focused on GIST

Imatinib,a tyrosine kinase inhibitor, has been demonstrated to be effective in the treatment of unresectable or metastatic GISTs by inhibition of...

Slide Library

Management of Advanced Prostate Cancer: Current Concepts

Prostate cancer has become a major public health burden worldwide and its incidence rates are increasing in India.  Hormonal therapy or androgen...

 
Email this page
Clinical Appraisal of Abiraterone acetate in Management of CRPC

Prostate cancer has become a major public health burden worldwide. Castration or hormonal therapy is the mainstay of treatment for the management of...

 
Email this page
HBV Reactivation in Patients Undergoing Chemotherapy

The risk of hepatitis B virus (HB) reactivation is high in patients receiving chemotherapy for solid or hematological malignancies which may lead to...

 
Email this page
Haematological Malignancies

Haematological malignancies are the types of cancer that affect blood, bone marrow and lymph nodes. This slide set includes types, risk factors,...

 
Email this page

Key Trials

Efficacy of 6 Months of Capecitabine vs. 12 Months as Adjuvant Chemotherapy for Patients with Stage III CRC

This is the first phase III trial on postoperative adjuvant chemotherapy in which the duration of oral 5-fluoropyrimidine drug for colorectal cancer...

Efficacy and Safety of mXELIRI Regimen versus Standard FOLFIRI Regimen, W or W/o Bevacizumab as a Second-line Therapy for Metastatic Colorectal Cancer

This study is the first phase 3 randomised trial evaluating whether the mXELIRI regimen is non-inferior to the standard FOLFIRI regimen, with or...

ENSURE Trial: Erlotinib versus Gemcitabine/cisplatin as First-line Treatment in EGFR mutation-positive Non-small-cell Lung Cancer Patients

ENSURE was the first and largest trial to prospectively investigate erlotinib versus chemotherapy in a broad Asian population. The study showed that...

Efficacy and Safety of Intravesical Bacillus Calmette-Guérin Immunotherapy in Patients with Non-Muscle-Invasive Bladder Cancer Presenting with Asymptomatic Bacteriuria (ABU)

This study provides you a brief insight on the efficacy and safety of intravesical BCG instillations when used in patients with Non-Muscle-Invasive...

Patient Education

All You Wanted to Know About Thyroid Cancer

Thyroid cancer is relatively uncommon compared to other cancers. This input describes the risk factors, symptoms, diagnosis and over all treatment fo...

All You Wanted to Know about Prostate Cancer

Prostate is one of the most common cancers in men. This material describes risk factors, symptoms, diagnosis and treatment of prostate cancer. Also,...

Living with Leukemia/Lymphoma

Tips for patient with leukaemia and lymphoma are explained along with pictures for better understanding. 

All You Wanted to Know about Ovarian Cancer

Risk factors, signs & symptoms, factors known to reduce ovarian cancer, diagnosis, treatment options and how to reduce risk of ovarian cancer giv...

Poll

Your choice of drug in the first-line treatment of patients with metastatic colorectal cancer treatment (CRC)
Capecitabine
44% (4 votes)
Tegafur uracil
0% (0 votes)
5-FU
56% (5 votes)
Total votes: 9